Cymbalta caused dangerous skin condition, lawsuit says 
Published: January 30, 2012
Tags: Cymbalta, defective design, drug litigation, Eli Lilly, FDA, Food and Drug Administration, Stevens-Johnson Syndrome, strict liability
A Kansas woman has filed a product liability suit against Eli Lilly, claiming she suffered a life-threatening skin condition known as Stevens-Johnson syndrome as a result of taking the drug company’s anti-depressant Cymbalta.
Watchdog cites conflicts in calling for new Yaz panel
Published: January 25, 2012
Tags: Bayer, birth control, birth control litigation, FDA, Food and Drug Administration, Yasmin, Yaz
An independent watchdog group has asked the Food and Drug Administration to disregard a safety panel’s recommendation to keep the popular birth control drugs Yaz and Yasmin on the market, citing evidence that several panel members operated under conflicts of interest.
FDA increases restrictions on heart drug after review
Published: January 9, 2012
Tags: atrial fibrillation, FDA, Food and Drug Administration, Multaq
Following a safety review of the heart drug Multaq, the Food and Drug Administration has recommended greater restrictions for the medication.
Ariz. woman sues heartburn drug makers over bone fractures
By:
Pat Murphy
Published: December 23, 2011
Tags: acid reflux, AstraZeneca, FDA, Food and Drug Administration, Nexium, Pfizer, product liability, proton pump inhibitors
An Arizona woman has filed a product liability lawsuit alleging that she suffered bone fractures in her feet as a result of taking popular heartburn drugs made by AstraZeneca, Pfizer and other pharmaceutical companies.
FDA: Beware of gastric lap band ads
Published: December 23, 2011
Tags: FDA, Food and Drug Administration, gastric lap bands, lap bands
The Food and Drug Administration recently sent warning letters to eight surgical centers and a marketing company, cautioning recipients about misleading advertisements for gastric lap band procedures.
FDA panels vote in favor of stronger Yaz warnings
Published: December 14, 2011
Tags: Bayer, birth control, birth control litigation, contraceptives, FDA, Food and Drug Administration, Yasmin, Yaz
Two federal advisory panels voted earlier this month in favor of requiring Bayer AG to update warning labels on its popular birth control drug Yaz to reflect new concerns of an increased risk of blood clots.
Pharmaceutical firm liable for wrongful discharge
Published: December 13, 2011
Tags: Food and Drug Administration, wrongful discharge
A pharmaceutical company violated state public policy when it fired a sales representative after she objected to plans to sell products for “off-label” uses and refused to circumvent federal anti-kickback laws, the 6th Circuit has ruled in affirming an $880,000 verdict.
Bellwether vaginal mesh lawsuits set for trial
Published: November 28, 2011
Tags: Food and Drug Administration, pelvic mesh, vaginal mesh
Bellwether trials in consolidated lawsuits over Johnson & Johnson subsidiary Ethicon Gynecare’s pelvic mesh products have been set for trial in New Jersey state court late next year.
Yaz plaintiff loses bid to unseal documents for FDA
Published: November 23, 2011
Tags: class action, Discovery, Food and Drug Administration, multidistrict litigation, Yasmin, Yaz
The Food and Drug Administration will not be given access to documents relating to the safety of drospirenone-containing oral contraceptives that pharmaceutical company Bayer has kept confidential in the Yaz and Yasmin multidistrict product liability litigation.
FDA pulls Avastin approval
Published: November 21, 2011
Tags: Avastin, breast cancer, drug approval, Food and Drug Administration
WASHINGTON – The Food and Drug Administration has revoked its approval of the drug Avastin for breast cancer treatment, saying the drug has not been shown to be safe and effective for that use.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
